Skip to main content
. 2026 Jul 24;31(15):2594. doi: 10.3390/molecules31152594
AD Alzheimer’s disease
Aβ Amyloid-β
NFTs Neurofibrillary tangles
APP Amyloid precursor protein
AICD APP intracellular domain
APOE Apolipoprotein E
AChE Acetylcholinesterase
MAP Microtubule-associated protein
MTs Microtubules
NF-κB Nuclear factor kappa-B
ACh Acetylcholine
OS Oxidative stress
ROS Reactive oxygen species
ER Endoplasmic reticulum
HO-1 Heme oxygenase-1
NQO-1 NAD(P)H:quinone oxidoreductase 1
CAT Catalase
SOD Superoxide dismutase
GPx Glutathione peroxidase
SNP Sodium nitroprusside
NO Nitric oxide
MAPK Mitogen-activated protein kinase
Nrf2 Nuclear factor erythroid 2-related factor 2
Keap1 Kelch-like ECH-associated protein 1
NAC N-acetylcysteine
BDNF Brain-derived neurotrophic factor
ATP Adenosine triphosphate
GSH-Px Glutathione peroxidase
GSH Glutathione
MDA Malondialdehyde
GSSG Oxidized glutathione
NADPH Nicotinamide adenine dinucleotide phosphate
NMDA N-methyl-D-aspartate
LPS Lipopolysaccharide
PGE2 Prostaglandin E2
MCP-1 Monocyte chemoattractant protein-1
p-IκBα Phosphorylated inhibitor of κB α
p-p65 Phosphorylated p65
PAT Passive avoidance task
MWM Morris water maze
IC50 Half-maximal inhibitory concentration
EF Electric foot shock
ERK1/2 Extracellular signal-regulated kinase
CREB CAMP response element-binding protein
Gsk3β Glycogen synthase kinase 3β
FSP1 Ferroptosis suppressor protein 1
INDO Inhibiting indomethacin
GI Gastrointestinal
BBB Blood–brain barrier
SMEDDS Self-microemulsifying drug delivery systems
SAR Structure–activity relationship
CETSA Cellular thermal shift assay
DARTS Drug affinity responsive target stability